For Immediate Release
Contact:
mkrgcomm@tams.com
TOSHIBA AMERICA MEDICAL SYSTEMS FEATURES VANTAGE ZGV MRI SYSTEM AT RSNA
Toshiba's Newest MRI System Offers New Sequences, High-Quality Images and Faster
CPU
RSNA Booth #
7114 (North Building, Hall B)
CHICAGO,
Nov. 29, 2005 – Toshiba America Medical Systems, Inc. (TAMS) today announced
the introduction of its high performance Vantage ZGV magnetic resonance imaging
(MRI) system—the highest-end 1.5T system available. The works-in-progress
Vantage ZGV features new product sequences, enhanced image quality, and the Mach
8 processor, a faster CPU allowing 1230 images per second reconstruction for more
powerful clinical applications. The system is currently installed and undergoing
evaluation at the Steinberg Diagnostic Medical Imaging (SDMI) Center in Las Vegas.
Images obtained
using the Vantage ZGV will be available for viewing at the Radiological Society
of North America’s (RSNA) annual meeting, held in Chicago Nov. 27-Dec. 2 in booth
#7114 (North Building, Hall B.)
“Toshiba’s Vantage
ZGV features industry-leading technology and is designed with exceptional patient
care and comfort in mind,” said Bob Giegerich, director, MR Business Unit, TAMS.
“With the new Mach 8 processor, the Vantage ZGV increases patient throughput and
broadens future upgrade capabilities.”
The Vantage ZGV
offers a gradient strength of 33 mT/m (milliTesla per meter) and a slew rate of
200 mT/m/sec (milliTesla per meter per second) and delivers the highest homogeneity
of any magnet in the industry over the full 50 cm diameter spherical volume (DSV).
Field upgrade kits to the new ZGV are available to current Vantage users.
Vantage
MRI—Unmatched Performance and Patient-Focused Features
Currently available in three other versions, the Vantage offers an ultra-short magnet
at 140 cm with linear 30 mT/m (milliTesla per meter) gradient strength with a slew
rate of 50 T/m/s (Tesla per meter per second) (AGV), 86 T/m/s (MGV) or 130 T/m/s
XGV).
The Vantage also
offers some of the most advanced MRI applications available in the market today,
including optional packages for cardiac imaging, advanced Echo Planar Imaging (EPI),
Perfusion and Diffusion Imaging, Peripheral MRA, and SuperFASE (Fast Advanced Spin
Echo) imaging. In addition, Toshiba has pioneered research into contrast-free
MRA with its Fresh Blood Imaging (FBI) protocol and Body Diffusion.
With Toshiba's
patented PianissimoTM technology, which reduces acoustic
noise by as much as 90 percent, the Vantage dramatically reduces the most significant
cause of patient discomfort and enables clinicians to better utilize all of the
system's high-field MRI capabilities including SPEEDER parallel imaging for increased
acquisition speed that reduces examination times. For more information about
the Vantage, TAMS and its wide range of medical imaging products, visit
www.medical.toshiba.com.
About
Toshiba
With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells,
distributes and services diagnostic imaging systems, and coordinates clinical diagnostic
imaging research for all modalities in the United States. Toshiba Medical
Systems Corporation, an independent group company of Toshiba Corporation, is a global
leading provider of diagnostic medical imaging systems and comprehensive medical
solutions, such as CT, X-ray, Ultrasound, Nuclear Medicine, MRI and information
systems. Toshiba Corporation is a leader in information and communications
systems, electronic components, consumer products, and power systems. Toshiba
has approximately 161,000 employees worldwide and annual sales of $53 billion.
Excelart VantageTM and PianissimoTM are
trademarks of Toshiba Medical Systems Corporation.
Contact Us 